Observational usage study of Faslodex in patients suffering from initial breast cancer in France

Study identifier:NIS-OFR-FAS-2007/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Observational usage study of Faslodex in patients suffering from initial breast cancer in France

Medical condition

Breast Cancer

Phase

-

Healthy volunteers

No

Study drug

-

Sex

Female

Actual Enrollment

217

Study type

Observational

Age

N/A

Date

Study Start Date: 01 May 2007
Primary Completion Date: -
Study Completion Date: 01 Jun 2007

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria